Atopic dermatitis (AD) is a chronic inflammatory ... topical calcineurin inhibitors (TCIs), phosphodiesterase inhibitors (Eucrisa), or janus kinase inhibitors (Opzelura)—for eczema treatment ...

Eucrisa gained approval based on two trials ... injectable drug Dupixent (dupilumab), but this is more acute forms atopic dermatitis. Roche and AstraZeneca also have antibody-based eczema ...

2,9-11 “As just one example of our innovative, science-based pipeline, Nemluvio is an important and effective new treatment option for patients with atopic dermatitis, where unmet needs remain.